Immunity Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

hello, everyone, and welcome to this speciaecial edition of "hannity". i'm tammy bruce. and for sean, on this last fridayn of han. tammy b of 2023. >> we begin with a shocking f displariy of authoritarianism in the state of all places, the state of mainenism. last night, secretary of state shenna bellows, a devout democrat, decided that shepowe alone has the power to pick and choose who is allowed to appear on the 2024on republican primary ballot. and of course, donal the rd trud not make the cut. >> maine's far left secretary. of state believes deep in her heart that trump committed...

Just one month into the year, it looks like 2024 might go down as one of the worst years on record for journalism. The body count alone is staggering: Nearly a quarter of the staff at the Los Angeles Times—at least 115 people—got the ax, as did reporters at Time magazine. The Wall Street Journal reorganized its D.C. bureau, cutting journalists from the masthead and shipping the survivors back to New York; The Washington Post used the new year to throw out another handful of its reporters followi

XOMA acquires future milestone economics and royalties associated with arimoclomol and aldoxorubicin, allowing LadRx to focus on core LADR assets

DelveInsight's analysts estimate that relapsed/refractory acute myeloid leukemia market is poised to show significant growth, mainly attributed to recent drug approvals, increasing incidence,

The antibody-drug conjugates market is anticipated to surge as several pharma companies across the globe are thoroughly working toward the development and expansion to treat a wide array of